中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2014年
9期
646-650
,共5页
金孝梁%陈志斌%王敏燕%吕文艳%张薇薇%孙建良
金孝樑%陳誌斌%王敏燕%呂文豔%張薇薇%孫建良
금효량%진지빈%왕민연%려문염%장미미%손건량
体外循环预充%血管外肺水%心肺功能%血浆胶体渗透压
體外循環預充%血管外肺水%心肺功能%血漿膠體滲透壓
체외순배예충%혈관외폐수%심폐공능%혈장효체삼투압
Cardiopulmonary bypass prime%Extravascular lung water%Cardiopulmonary function%Plasma colloid pressure
目的 探讨高渗胶体渗透压预充液体外循环(CPB)对冠脉搭桥患者术后早期血管外肺水和心肺功能的影响.方法 经医院伦理委员会审核通过,2010年1月至2013年4月解放军第一一七医院40例择期冠脉搭挢术患者,按随机数字表法分为高胶体渗透压组(HES组,n=20)和对照组(晶体液组,n=20),两组预充液总量相等,观察比较两组患者术后早期心肺功能、血管外肺水(EVLW)、血浆胶体渗透压(COP)、液体输入总量及体重增减等指标.结果 两组患者术前一般情况、CPB和主动脉阻断时间、冠脉吻合数均相似.CPB期间,HES组COP较转机前下降约22%[(16.7±3.9) 比(21.5±2.2) mmHg,P<0.05)],晶体液组下降超过50%[(10.7±2.0 ) 比(22.7±1.9 ) mmHg,P<0.05)].CPB结束后,HES组心脏指数(CI)显著高于晶体液组,且HES组的EVLW不变,而晶体液组增加21%,HES组的液体总入量也显著低于晶体液组[(715±544) 比 (1 951±487),P<0.05],晶体液组术后患者体重增加,但HES组则不增加[(1.4±1.1) 比(0.3±1.3),P<0.05],组间比较差异均有统计学意义(均P<0.05).其他血液动力学和心肺功能指标两组间各时间点比较均无显著差异.结论 高胶体渗透压预充液CPB可改善冠脉搭桥患者术后早期的CI,减少EVLW生成,但对肺功能无明显影响.
目的 探討高滲膠體滲透壓預充液體外循環(CPB)對冠脈搭橋患者術後早期血管外肺水和心肺功能的影響.方法 經醫院倫理委員會審覈通過,2010年1月至2013年4月解放軍第一一七醫院40例擇期冠脈搭撟術患者,按隨機數字錶法分為高膠體滲透壓組(HES組,n=20)和對照組(晶體液組,n=20),兩組預充液總量相等,觀察比較兩組患者術後早期心肺功能、血管外肺水(EVLW)、血漿膠體滲透壓(COP)、液體輸入總量及體重增減等指標.結果 兩組患者術前一般情況、CPB和主動脈阻斷時間、冠脈吻閤數均相似.CPB期間,HES組COP較轉機前下降約22%[(16.7±3.9) 比(21.5±2.2) mmHg,P<0.05)],晶體液組下降超過50%[(10.7±2.0 ) 比(22.7±1.9 ) mmHg,P<0.05)].CPB結束後,HES組心髒指數(CI)顯著高于晶體液組,且HES組的EVLW不變,而晶體液組增加21%,HES組的液體總入量也顯著低于晶體液組[(715±544) 比 (1 951±487),P<0.05],晶體液組術後患者體重增加,但HES組則不增加[(1.4±1.1) 比(0.3±1.3),P<0.05],組間比較差異均有統計學意義(均P<0.05).其他血液動力學和心肺功能指標兩組間各時間點比較均無顯著差異.結論 高膠體滲透壓預充液CPB可改善冠脈搭橋患者術後早期的CI,減少EVLW生成,但對肺功能無明顯影響.
목적 탐토고삼효체삼투압예충액체외순배(CPB)대관맥탑교환자술후조기혈관외폐수화심폐공능적영향.방법 경의원윤리위원회심핵통과,2010년1월지2013년4월해방군제일일칠의원40례택기관맥탑교술환자,안수궤수자표법분위고효체삼투압조(HES조,n=20)화대조조(정체액조,n=20),량조예충액총량상등,관찰비교량조환자술후조기심폐공능、혈관외폐수(EVLW)、혈장효체삼투압(COP)、액체수입총량급체중증감등지표.결과 량조환자술전일반정황、CPB화주동맥조단시간、관맥문합수균상사.CPB기간,HES조COP교전궤전하강약22%[(16.7±3.9) 비(21.5±2.2) mmHg,P<0.05)],정체액조하강초과50%[(10.7±2.0 ) 비(22.7±1.9 ) mmHg,P<0.05)].CPB결속후,HES조심장지수(CI)현저고우정체액조,차HES조적EVLW불변,이정체액조증가21%,HES조적액체총입량야현저저우정체액조[(715±544) 비 (1 951±487),P<0.05],정체액조술후환자체중증가,단HES조칙불증가[(1.4±1.1) 비(0.3±1.3),P<0.05],조간비교차이균유통계학의의(균P<0.05).기타혈액동역학화심폐공능지표량조간각시간점비교균무현저차이.결론 고효체삼투압예충액CPB가개선관맥탑교환자술후조기적CI,감소EVLW생성,단대폐공능무명현영향.
Objective To investigated the effect of a hyperoncotic CPB-prime with hydroxyethyl starch (HES) 6% (130/0.4) on extravascular lung water (EVLW) and post-pump cardiac and pulmonary functions.Methods This study plan approved by the hospital ethics committee review.In 40 randomized patients undergoing elective coronary artery bypass graft surgery (CABG), a colloid prime (COP:42.5 mmHg, HES-group,n=20) and a crystalloid prime (Ringer′s lactate, crystalloid group, n=20) of equal volume were compared with respect to the effects on cardiopulmonary function.Cardiac index (CI), mean arterial pressure (MAP),pulmonary capillary wedge pressure (PCWP), systemic vascular resistance index (SVRI), pulmonary artery pressure (PAP), pulmonary vascular resistance index (PVRI), alveolo-arterial oxygen difference (AaDO2), pulmonary shunt fraction (Qs/QT), extravascular lung water (EVLW), COP, fluid balance and body weight were evaluated peri-operatively.Results Pre-operative demographic and clinical data, CPB-time, crossclamp time and the number of anastomoses were comparable for both groups.During CPB, COP was reduced by 22% in the HES-group[(16.7±3.9) vs (21.5±2.2) mmHg, P<0.05] while it was reduced by more than 50% of the pre-CPB value [10.7±2.0 vs (22.7±1.9) mmHg,P<0.05] in the crystalloid group (P<0.05 HES-group vs. Crystalloid group).Post-CPB EVLW was unchanged in the HES-group but it was elevated by 21% in the crystalloid group (P<0.05 HES-group vs crystalloid group), CI was higher in the HES-group [(3.3±0.3) vs (2.7±0.7) L/min, P<0.05].Fluid balance was less in the HES-group (715±544 vs 1 951±487, P<0.05).Post-operative weight gain could be prevented in the HES-group but not in the crystalloid group (1.4±1.1 vs -0.3±1.3,P<0.05).No significant differences were seen for MAP, PAP, PCWP, SVRI, PVRI, AaDO2 and (Qs/QT) between the two groups at any time.Conclusions Hyperoncotic CPB-prime using HES 6% improves CI and prevents EVLW accumulation in the early post-pump period, while pulmonary function is unchanged.